Member Info for Wiggly

I see CTAG however I think I trust Al. Not long to wait either way.

I think disaster if we are not. I am fully loaded here so we better be

Will Q4 be transformational as you promised shareholders or were you pumping the price while you were house hunting?

The very least you should do is update shareholders with the latest guidance on expected time to market.

THE data presented is not the final analysis as it is based on only the first 94 VOLUNTEERS (FROM 43K) to develop Covid so the precise effectiveness of the vaccine may change when the full results are analysed.

How can they claim 90% effective based on this?

I administer flu vaccines every winter and still there's thousands and thousands who still get hospitalised and die from flu

Really good point. Cv is far deadlier than Flu, thus to keep society safe I don't see any near term end to testing.

Even if Tt not yet complete, some added details explaining where we are in the process would help calm nerves

We still have a very good chance of success.

The West might get vaccinated in numbers by h1 2021 but poorer nations will rely on cheap point of care testing..

Also, even with the west vacinated I would think the global market for airlines, dentists, concerts, offshore workers etc will all likely continue with extra safety measures (cheap point of care testing) for many years.

The prize is still there for a best in class LFT. Al could have rushed the LFT out the door but decided to address all risks upfront.

See nhs tender released yesterday. For ltf 3.5 month supply, £912m value.

Chances this could be avct?

Sir Al said q4 was to be transformational for shareholders.

I still have faith.

Considering Al missed all of the summer deadlines he certainly does owe loyal investors an update tomorrow

Fully loaded and awaiting Tt + BAMS news.

The main problem is that the vaccine(s) being developed will not work well for this strain.

Fortunately, avct will be able to rapidly develop Affimers to identify this strain.

https://www.dailymail.co.uk/news/article-8923787/WHO-says-mutant-mink-coronavirus-outbreak-Denmark-concern.html

Story developing for the worse

I don't think any other tests are being validated against 30k samples. This, in my view, indicates that it is extremely high performing (we do know that it is likely to have exquisite spec) and thus they are aiming to prove without doudt that it is a new gold standard test.

For Avacta, this news is actually very positive.

The advantage of Affimers vs antibodies is that they can be generated more quickly and with higher spec.

If you are about to invest in a multi million $$ contract for supply of lfts I think you want to know that they can be adapted quickly to capture any and all future mutations..

Can the antibody based diagnostics be adapted as quickly as the Affimer avct LFT?

Correct, the current vaccine is not likely to work against this mutant strain, similar to the 2019 flu vaccine not working for the 2021 flu.

Coronavirus: Denmark imposes lockdowns amid mink covid fears

https://news.sky.com/story/coronavirus-denmark-off-travel-corridor-list-after-covid-19-outbreak-hits-mink-farms-12125059

Absolute disaster and could if not brought under control will knock back vaccine work by 12 months.

Phantom, excuse me??

What did the bofoon say?

Mass spec machines also part of the scope!